Milestone Pharmaceuticals (MIST) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Milestone Pharmaceuticals (MIST) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Milestone Pharmaceuticals

· MIST

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

102.088 M

+5.57%

General

Market Cap: $102.09M
Enterprise Value: $79.88M
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 94.58%
Operating Margin: -3353.01%
Net Profit Margin: -3585.62%
FCF Margin: -2612.73%
ROA: -46.26%
ROE: -288.36%
ROIC: -48.96%
Current Ratio: 8.13
Debt-to-Equity: 7.79
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 46.00
P/FCF: —
P/B: 5.92
EV/EBITDA: -1.09

Growth

Rev 1Y: —
Rev 1Y Fwd Est: 147.62%
Rev 3Y (CAGR): -32.38%
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR)

Income Statement (TTM)

Revenue: $2.34M
Gross Margin: 94.58%
Operating Expenses: $80.78M
Operating Income: -$78.56M
Net Profit: -$84.01M

Balance Sheet

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $169.73M
Working Capital: $158.14M
Total Assets: $181.63M
Net Debt: -$27.9M
Total Liabilities: $163.41M
Total Equity: $18.22M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$61.18M
Cash Flow from Investing: -$1.13M
Cash Flow from Financing: $189.1M
Free Cash Flow: -$61.22M
Capital Expenditures: $38.65K